The impact of disease-drug interactions on drug development and clinical practice

被引：5
|
作者：
Cai, Hualin [1 ,2 ]
Chen, Xia [3 ,4 ]
机构：
[1] Cent South Univ, Dept Pharm, Xiangya Hosp 2, Changsha, Peoples R China
[2] Cent South Univ, Inst Clin Pharm, Changsha, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, Phase Unit 1, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Tiantan Hosp, Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2021年 / 87卷 / 03期
关键词：
PHARMACOKINETICS;
D O I：
10.1111/bcp.14469
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：712 / 714
页数：3
相关论文
共 50 条
  • [1] Transcriptional Regulation of Disease-Drug Interactions
    Xie, Wen
    FASEB JOURNAL, 2017, 31
  • [2] Exploring disease-drug pairs in Clinical Trials information for personalized drug repurposing
    Alvarez-Perez, Andrea, I
    Prieto-Santamaria, Lucia
    Ugarte-Carro, Esther
    Otero-Carrasco, Belen
    Ayuso-Munoz, Adrian
    Rodriguez-Gonzalez, Alejandro
    2023 IEEE 36TH INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS, CBMS, 2023, : 179 - 184
  • [3] The impact of genomics on drug development and clinical practice
    Bernards, Rene
    ANNALS OF ONCOLOGY, 2004, 15 : 2 - 2
  • [4] Disease-Drug Interactions in Inflammatory States via Effects on CYP-Mediated Drug Clearance
    Coutant, David E.
    Hall, Stephen D.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (07): : 849 - 863
  • [5] Risk of drug-disease and disease-drug interactions with anticonvulsants in HIV-positive patients - Reply
    Tseng, ALI
    Foisy, MM
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (12) : 1373 - 1374
  • [6] Drug-drug interactions in clinical practice
    Depont, Fanny
    Vargas, Frederic
    Dutronc, Herve
    Giauque, Emmanuelle
    Ragnaud, Jean-Marie
    Galperine, Tatiana
    Abouelfath, Abdelilah
    Valentino, Ruddy
    Dupon, Michel
    Hebert, Guillaume
    Moore, Nicholas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (11) : 1227 - 1233
  • [7] Human liver spheroids in chemically defined conditions for studies of gene-drug, drug-drug and disease-drug interactions
    Ingelman-Sundberg, Magnus
    Lauschke, Volker M.
    PHARMACOGENOMICS, 2018, 19 (14) : 1133 - 1138
  • [8] Improving the Working Models for Drug-Drug Interactions: Impact on Preclinical and Clinical Drug Development
    Nguyen, James
    Joseph, David
    Chen, Xin
    Armanios, Beshoy
    Sharma, Ashish
    Stopfer, Peter
    Huang, Fenglei
    PHARMACEUTICS, 2025, 17 (02)
  • [9] Venlafaxine drug-drug interactions in clinical practice
    Benazzi, F
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1998, 23 (03): : 181 - 182
  • [10] Drug Repositioning with Disease-Drug Clusters from Word Representations
    Lee, Dong-gi
    Kim, Myungjun
    Shin, Hyunjung
    2022 IEEE INTERNATIONAL CONFERENCE ON BIG DATA AND SMART COMPUTING (IEEE BIGCOMP 2022), 2022, : 182 - 189
12345